OSI Systems, Inc. — Form 10-Q Summary
Business Context and Reporting Period
OSI Systems designs and manufactures specialized electronic systems and components for homeland security, healthcare, defense and aerospace markets. Its operating divisions are Security, Healthcare, and Optoelectronics and Manufacturing. This unaudited report covers the three months ended September 30, 2011, the first quarter of fiscal 2012, compared with the three months ended September 30, 2010.
Key Financial Metrics
| Metric | Q1 FY2012 | Q1 FY2011 | Change |
|---|---|---|---|
| Revenue | $161.3 million | $128.5 million | Up 26% |
| Gross profit | $52.9 million | $46.9 million | Up 13% |
| Gross margin | 32.8% | 36.5% | Down 3.7 points |
| Income from operations | $7.6 million | $5.4 million | Up 40% |
| Operating margin | 4.7% | 4.2% | Up 0.5 points |
| Net income | $4.8 million | $3.4 million | Up 40% |
| Diluted EPS | $0.24 | $0.18 | Up $0.06 |
| Cash flow from operations | $10.0 million | $9.6 million | Up 4% |
Net margin was approximately 3.0%, compared with 2.6% in the prior-year quarter. The effective tax rate was 30.1%, compared with 30.0%. Comprehensive income declined to $1.8 million from $8.5 million because foreign-currency translation shifted from a $4.9 million gain to a $3.3 million loss.
At September 30, 2011, cash and cash equivalents were $58.4 million, up from $55.6 million at June 30, 2011. Working capital was $256.0 million. Inventories increased to $188.0 million from $169.6 million, primarily to support future Security shipments.
Total debt was approximately $2.9 million. The $250 million revolving credit facility had no borrowings outstanding, although $71.7 million was outstanding under its letter-of-credit facility. Foreign subsidiaries had $17.2 million outstanding under letter-of-credit facilities, with no related debt borrowings.
Material Changes Versus the Prior Comparable Period
- Security revenue increased 42% to $72.6 million, driven by higher cargo, vehicle, baggage and people-screening equipment sales and higher service revenue.
- Healthcare revenue increased 1% to $46.5 million; higher patient-monitoring sales largely offset declines in cardiology and anesthesia equipment.
- Optoelectronics and Manufacturing revenue increased 27% to $53.1 million, primarily due to a 59% increase in commercial optoelectronics sales.
- Gross margin contracted because of a less favorable mix toward lower-margin Security and Optoelectronics businesses, product mix, and cost overruns involving Security subcontractors.
- SG&A increased 8% to $34.4 million, while R&D increased 18% to $10.9 million to support growth and new product introductions. Restructuring charges declined from $0.3 million to zero.
- Operating cash flow was broadly stable despite higher earnings, with working-capital benefits partly offset by an unfavorable $28.7 million year-over-year accounts-receivable effect associated with sales growth.
- Investing cash use increased to $7.2 million from $4.7 million, including $3.2 million for acquisitions and $3.2 million for capital expenditures.
- The company acquired an immaterial Security business, adding approximately $5.6 million of goodwill and $7.6 million to estimated contingent payment obligations.
Outlook, Risks, Contingencies and Unusual Items
The filing provides no specific quantitative revenue, earnings or margin guidance. Management states that healthcare customers have delayed purchases amid economic uncertainty and that prolonged weakness could materially affect results. International operations expose the company to regulatory, geopolitical, collection, tariff and currency risks. A 10% appreciation or depreciation of the U.S. dollar against relevant local currencies was estimated to change quarterly operating income by approximately $2 million in the opposite direction.
The company had approximately $8.7 million of foreign-currency forward contracts outstanding at September 30, 2011. A non-hedge-designated contract contributed to higher other expense. The company reported no material changes in market risk and no significant off-balance-sheet arrangements.
Contingent consideration from acquisitions had a maximum potential payment of $52 million, with $16.5 million recorded in other long-term liabilities. Certain acquisition-related royalty payments continue through 2022. The company is involved in ordinary-course litigation and environmental matters, including contamination investigations in California and Mississippi; no amounts were accrued because unfavorable outcomes were not considered probable and reasonably estimable, although an adverse resolution could be material.
Management concluded that disclosure controls and procedures were effective as of September 30, 2011, and reported no material changes in internal control over financial reporting. The filing states that there were no material changes to the risk factors disclosed in the fiscal 2011 Form 10-K.
Important Facts for Investors to Verify
- Whether the strong Security and Optoelectronics revenue growth is sustainable and whether gross margins recover from the 32.8% quarterly level.
- Inventory growth, receivable collections and the company’s ability to convert higher sales into operating cash flow.
- The magnitude and timing of acquisition-related contingent payments, including the $16.5 million recorded liability and $52 million maximum exposure.
- Healthcare demand trends and the effect of delayed hospital purchasing on future revenue.
- Availability under revolving and letter-of-credit facilities and compliance with related covenants.
- Potential exposure from litigation, environmental matters, warranties and foreign-currency movements.